Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Accelerated Access Review

- PMLiVE

Eleven Magical Years for Lucid Group

Lucid Group celebrated their eleventh birthday today. They served up plenty of cake and excitement, distributing invitations for family and friends to attend the Lucid Magic festival, which is being...

Lucid Group Communications Limited

Roche Basel Switzerland

NICE backs Roche’s Gazyvaro after initial rejection

An undisclosed discount swayed the cost-effectiveness body

- PMLiVE

Roche’s lung drug Esbriet reserved for worse cases, says NICE

Boehringer Ingelheim’s Ofev subject to same conditions

- PMLiVE

World Cancer Day and the role of people-centred care

How people-centred is current cancer care? To support #WorldCancerDay, we explore this question, and look at the ways we can individually and collectively reduce the burden of cancer.

Porterhouse Medical Group

- PMLiVE

Porterhouse speakers to focus on skills, data sharing and transparency at 17th TIPPA Meeting

Strategies to Improve Operations and Compliance in Medical Communications

Porterhouse Medical Group

- PMLiVE

Lucid look set to expand their Macclesfield team

This week Business Unit Heads from Lucid Group met with potential candidates at their Macclesfield office to interview for a number of key roles within the organisation. The recruitment drive...

Lucid Group Communications Limited

- PMLiVE

Lucid present their ambitious plans to spread their magic across the industry

Lucid held their first breakfast meeting with top industry recruiters from across the UK to discuss their plans for expansion and recruitment for the year ahead. CEO and Co-Founder Dennis...

Lucid Group Communications Limited

Porterhouse Medical Group charity round-up 2017

Porterhouse Medical Group charity round-up for 2017

As part of the Porterhouse Medical Group’s mission to help improve people’s lives, we use our communications expertise to raise awareness of diseases, and participate in many fund-raising activities for...

Porterhouse Medical Group

- PMLiVE

NICE backs trial of online and mobile depression programme

First digital psychological therapy briefing covers Servier and Gaia's Deprexis

Biogen Idec building

NICE finally starts review of Biogen’s Spinraza for SMA

Will evaluate the treatment based on its Single Technology Appraisal process

- PMLiVE

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

The bone marrow cancer therapy is now temporarily approved as a fourth-line treatment

Through the Looking Glass

Non-traditional innovation

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links